Another patent for a cannabinoid-based cream to treat pain has been granted to IGC.

The corporation has offices in the US, India, and Hong Kong. India Globalization Capital, Inc. is situated in Potomac, Maryland, and was founded in 2005. ... read more

The United States Patent and Trademark Office ("USPTO") granted India Globalization Capital, Inc. (the "Company") (NYSE American: IGC) another patent (patent#10,933,082) for the Company's cannabinoid composition and method for treating pain in patients with Psoriatic Arthritis, Fibromyalgia, Scleroderma, and other conditions on March 2, 2021.

Newest patent approval

On October 1, 2018, the patent application was submitted. The newest patent approval complements the Company's current patent portfolio, which includes USPTO patents for seizure disorders and eating disorders.

IGC is divided into two divisions: infrastructure and life sciences. The headquarters of the company are in Potomac, Maryland, United States of America.


EXECUTIVE LEADERSHIP
Richard K. Prins

Independent Chairman of the Board
Claudia Grimaldi

Vice President, Principal Financial Officer
Rohit Goel

Manager and Principal Accounting Officer
John E. Lynch

Sources: